The Lancet Oncology in conversation with
Total duration:
10 h 32 min
James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean
The Lancet Oncology in conversation with
35:05
Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials
The Lancet Oncology in conversation with
11:22
Maria Kyrgiou on innovations in gynaecological cancers and global disparities
The Lancet Oncology in conversation with
25:42
Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers
The Lancet Oncology in conversation with
34:43
Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer
The Lancet Oncology in conversation with
16:06
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma
The Lancet Oncology in conversation with
13:53
Neerja Bhatla on a new quadrivalent HPV vaccine
The Lancet Oncology in conversation with
12:24
Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery
The Lancet Oncology in conversation with
43:49
Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma
The Lancet Oncology in conversation with
17:10
Wanda Cui on measuring ovarian toxicity
The Lancet Oncology in conversation with
10:37
Ticiana Leal on Tumour Treating Fields
The Lancet Oncology in conversation with
09:01
Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA
The Lancet Oncology in conversation with
12:31
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma
The Lancet Oncology in conversation with
33:50
Madeline Pe on the SISAQOL initiative
The Lancet Oncology in conversation with
14:01
Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children
The Lancet Oncology in conversation with
28:40
Mark Lythgoe on UK oncology drug approval after Brexit
The Lancet Oncology in conversation with
14:11
Janet Brown on the phase 2/3 STAR trial
The Lancet Oncology in conversation with
20:43
Valerie Speirs on biomarkers in male breast cancer
The Lancet Oncology in conversation with
17:40
Sameer Bakhshi on sex disparities in childhood cancer in India
The Lancet Oncology in conversation with
23:02
Shankar Siva on radiotherapy for primary renal cell carcinoma
The Lancet Oncology in conversation with
08:30
Mark Lawler and Richard Sullivan on the European Groundshot
The Lancet Oncology in conversation with
23:20
Samar Alhomoud on challenges for cancer control in the Gulf region
The Lancet Oncology in conversation with
11:27
Inge Marie Svane on mRNA vaccines for cancer treatment
The Lancet Oncology in conversation with
08:11
Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer
The Lancet Oncology in conversation with
11:39
Ignace Vergote and Maria Kyrgiou on gynaecological cancers
The Lancet Oncology in conversation with
10:30
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
The Lancet Oncology in conversation with
05:19
Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa
The Lancet Oncology in conversation with
30:55
Georgios Lyratzopoulos on emergency presentation
The Lancet Oncology in conversation with
13:44
Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors
The Lancet Oncology in conversation with
12:53
Rosie Bradley on early-stage breast cancer treatment
The Lancet Oncology in conversation with
04:33
Yi-Long Wu and Caicun Zhou on non-small-cell lung cancer
The Lancet Oncology in conversation with
09:56
Rebecca Fitzgerald on Barrett's oesophagus surveillance
The Lancet Oncology in conversation with
07:25
Elysia Alvarez on adolescent and young adult cancer
The Lancet Oncology in conversation with
04:05
Aju Mathew on cancer care in India
The Lancet Oncology in conversation with
06:08
David Pinato on cancer patients who recovered from SARS-CoV-2 infection
The Lancet Oncology in conversation with
08:33
James Glasbey on the effect of lockdowns on cancer surgery
The Lancet Oncology in conversation with
07:12
Manju Sengar and Christopher Booth on essential cancer drugs
The Lancet Oncology in conversation with
11:55
Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi on helping with cancer control in LMICs
The Lancet Oncology in conversation with
28:02
Harriet Rumgay on the burden of cancer attributable to alcohol
The Lancet Oncology in conversation with
06:45
Rafael Cardoso and Hermann Brenner on colorectal cancer
The Lancet Oncology in conversation with
06:41